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Abstract
Introduction: The HIV epidemics in the Caribbean, Central America and South America (CCASA), Eastern Europe (EE) and Asia
and Pacific (AP) regions are diverse epidemics affecting different key populations in predominantly middle-income countries.
This narrative review describes the populations of HIV-positive youth approaching adolescence and adulthood in CCASA, EE
and AP, what is known of their outcomes in paediatric and adult care to date, ongoing research efforts and future research
priorities.
Methods: We searched PubMed and abstracts from recent conferences and workshops using keywords including HIV,
transition and adolescents, to identify published data on transition outcomes in CCASA, EE and AP. We also searched within
our regional clinical/research networks for work conducted in this area and presented at local or national meetings. To give
insight into future research priorities, we describe published data on characteristics and health status of young people as
they approach age of transition, as a key determinant of health in early adulthood, and information available on current
transition processes.
Results and discussion: The perinatally HIV-infected populations in these three regions face a range of challenges including
parental death and loss of family support; HIV-related stigma and socio-economic disparities; exposure to maternal injecting
drug use; and late disclosure of HIV status. Behaviourally HIV-infected youth often belong to marginalized sub-groups, with
particular challenges accessing services and care. Differences between and within countries in characteristics of HIV-positive
youth and models of care need to be considered in comparisons of outcomes in young adulthood. The very little data
published to date on transition outcomes across these three regions highlight some emerging issues around adherence,
virological failure and loss to follow-up, alongside examples of programmes which have successfully supported adolescents to
remain engaged with services and virologically suppressed.
Conclusions: Limited data available indicate uneven outcomes in paediatric services and some shared challenges for
adolescent transition including retention in care and adherence. The impact of issues specific to low prevalence, concen-
trated epidemic settings are poorly understood to date. Outcome data are urgently needed to guide management strategies
and advocate for service provision in these regions.
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Introduction
The HIV epidemics in the Caribbean, Central America and
South America (CCASA), Eastern Europe (EE) and Asia and
Pacific (AP) regions are diverse, concentrated epidemics
affecting different key populations, in predominantly mid-
dle-income countries. Adolescents (10–19 years) living
with HIV numbered 74,000 in CCASA and 220,000 in AP
in 2015, with 210,000 and 600,000, respectively, aged
15–24 years according to UNAIDS estimates [1]; the epi-
demic in EE and Central Asia is smaller (estimated 80,000
15–24 year olds), but the only one globally where overall
incidence continues to rise substantially. Successes in
prevention of mother-to-child transmission (PMTCT) have
been uneven across countries in these regions [2–7] and
alongside a perinatally HIV-infected (PHIV) population
aging into adolescence and young adulthood [8–10],
there is ongoing vulnerability of young people in margin-
alized key populations to behavioural HIV acquisition.
Almost a third of new infections in CCASA in 2014 were
in men who have sex with men (MSM), while in EE and
Central Asia, over half of new infections are currently
among people who inject drugs (PWID) [6]; young people
within key population groups are particularly vulnerable to
HIV acquisition and barriers to care [11,12].
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Paediatric HIV research capacity and infrastructure is very
limited in some of the most affected countries across CCASA,
EE and AP. Paediatric HIV in these regions is at risk of being
perceived as low priority compared with epidemics in key
adult populations and much larger numbers of PHIV children
living in sub-Saharan Africa, and this is reflected in a paucity
of paediatric HIV research literature specific to these set-
tings. For example, a recent systematic review of 2008–2013
data from low- and middle-income countries on paediatric
retention in HIV care reported results from several large
cohorts in Southern and Eastern Asia but only one in
CCASA and none in Europe or Central Asia [13]. In countries
with more mature epidemics, adolescence and the transition
to adult HIV services has been associated with issues around
retention and adherence, with outcomes of worsening
immune status [14] and increased risk of virological failure
[15,16]. PHIV and behaviourally HIV-infected (BHIV) young
people in CCASA, EE and AP regions may face challenges
specific to low prevalence, concentrated epidemic settings
including issues around organization and level of healthcare
resource and access, opportunities for peer support, and
punitive treatment of most-at-risk populations.
This narrative review describes the populations of HIV-
positive youth approaching adolescence and adulthood in
CCASA, EE and AP, what is known of their outcomes in
paediatric and adult care to date and ongoing research
efforts and future research priorities.
Methods
We searched PubMed and abstracts from recent conferences
and workshops for published information on adolescent transi-
tion in CCASA, EE and AP using key words including HIV,
transition and adolescents, to identify published data on transi-
tion outcomes. We also searched within our regional clinical/
research networks for work conducted in this area and pre-
sented at local or national meetings. We focussed on studies
exploring outcomes following transition to adult care (including
clinical or immunological /virological outcomes, ARV resistance,
loss to follow-up, death). Due to the paucity of data on post-
transition outcomes, we also describe published data on char-
acteristics and health status of young people as they approach
age of transition, as a key determinant of health in early
adulthood, and information available on current transition
processes, to give insight into future research priorities.
Results and discussion
Characteristics of HIV-positive young people
PMTCT and paediatric treatment policies, both current and
historic, require consideration in understanding the charac-
teristics of the populations of PHIV young people who,
alongside BHIV young people, require youth-orientated ser-
vices in these regions.
Caribbean, Central America and South America
In CCASA, PMTCT programmes have been in place through-
out the region since the late 1990s and around 74% of
pregnant women have access to HIV testing and
counselling; MTCT rates among diagnosed women in most
affected countries are now around 4–5% [4]. The largest
number of adolescents living with HIV are in Brazil and
Mexico (28,000 and 6,600, respectively [1]). Many PHIV
adolescents have been followed and treated since the
first months of life. Nevertheless, late diagnosis of children
still occurs; an observational study conducted at 15 paedia-
tric sites in Brazil, Argentina, and Mexico analyzed data of
120 adolescents who acquired HIV from diverse sources,
and found that 28% of the PHIV group were diagnosed at
≥10 years [17]. In this region, because of substantial HIV-
related stigma, parents frequently avoid bringing older chil-
dren to get tested or delay disclosure to young people of
their HIV status [18].
CCASA has a large population of young people aged
15–24 years strongly affected by socio-economic inequal-
ities, with more than 30% living in poverty [19]. Early sexual
debut and adolescent pregnancy is common in the region
(10% of women 15–19 years are mothers [19]), and data
from Haiti have shown particular vulnerability of young
women to sexual HIV acquisition [20]. Although the number
of new infections among adolescents has declined in recent
years and the estimated prevalence of HIV is below 1%
overall in CCASA, prevalence is much higher among some
key urban populations including young MSM (e.g. 13%
among adolescent MSM in Paraguay [21,22]).
Eastern Europe (EE)
Eastern Europe’s HIV epidemic began in Ukraine in the mid-
1990s, driven by injecting drug use (IDU) although with
increasing infections over time in bridging populations
(such as sexual partners of PWID) [23]. Currently, 8 in 10
new infections in EE and Central Asia are in Russia [6],
which together with Ukraine accounts for around 90% of
the people living with HIV (PLWH) in the region [24]. In
Russia and Ukraine, antenatal prevalence is around 0.75%
and 0.33%, respectively [25,26] and MTCT rates among
diagnosed women are currently around 3–4% [23,27] hav-
ing declined from 10% in 2003 in Ukraine [28] and around
5–8% in 2004–2005 in St Petersburg [29]. The region there-
fore has a comparatively young PHIV population; according
to official figures, of 6454 PHIV children in HIV care in
Russia in 2014, only 6% were aged over 14 years [27] (vs.
65% in the UK the same year [30]) while in the Ukraine
Paediatric HIV Cohort study which covers around a third of
PHIV children nationwide, median age at the beginning of
2016 was 10 years [IQR 6.9–13.0] [10]. In 2015, 97 young
people transferred from paediatric to adult HIV care nation-
ally in Ukraine at age 18 years [31] while there were 2764
children aged ≤14 years in HIV care [23]. PHIV children
growing up in EE have high prevalence of exposure to
maternal drug use (26% in the Ukraine Paediatric HIV
Cohort [32]) due to poor PMTCT access among women
who inject drugs [29,33] with potential for other related
impacts on health – for example, hepatitis C co-infection,
exposure to tuberculosis, and long-term sequelae of pre-
term delivery. Maternal IDU and perinatal HIV transmission
have both been linked to infant abandonment [34], and
high and increasing number of AIDS deaths in the adult
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population from 38,000 to 47,000 annually between 2010
and 2015 [35]) contribute to the number of PHIV children
growing up without family support in EE. For those in foster
or state institutional care [36,37], transition to adulthood
may bring its own challenges, with abrupt shift in available
support and responsibilities.
In Romania, a major iatrogenic HIV epidemic occurred in
1987 to the early 1990s among children who received
unsafe injections and/or blood [38]; an estimated 10,000
children were infected and many survivors have been fol-
lowed into adulthood [39,40]. Among new cases in young
people in Ukraine and Russia, IDU continues to be an
important mode of acquisition with injecting typically
initiated in the late teens or early 20s [41,42] and limited
coverage of harm reduction services [43]. Among street-
involved youth, HIV prevalence of up to 28% has been
recorded in the 15–24-year age group in Ukraine
[37,44,45] with two-thirds in one study engaged in bridging
behaviours with non-street youth [46]. There is also an
epidemic among MSM which is largely absent from official
figures [47,48] due to intense stigma and the hostile social/
legal environment experienced by this group [49]. National
data from Ukraine indicate a decline in the number of
15–24 year olds newly registering for HIV care from 34.5
to 18.9 per 100,000 between 2010 and 2015. However, less
than half of PLWH are estimated to be diagnosed and late
diagnoses with advanced disease are common [23].
Asia and Pacific (AP)
In AP, HIV PMTCT programmes were rolled out from the
late 1990s; however, the regional coverage of ART for
PMTCT in 2015 was only 41% [50]. Thailand is the only
country in Asia to meet the goal of elimination of MTCT,
with rates <2% in 2016, and a decline in antenatal preva-
lence from 2.3% in 1994 to 0.6% in 2015 [5]. Overall, access
to ART among HIV-infected children and adults in the AP
region began in the early 2000s [51] but with variable
funding in each country from National budgets, the Global
Fund to Fight AIDS, Tuberculosis and Malaria or the U.S.
President’s Emergency Plan for AIDS Relief (PEPFAR).
According to UNICEF, in 2015 there were more than
400,000 children orphaned to AIDS living in Indonesia,
Thailand, Myanmar and Vietnam [50]. The TREAT Asia
Pediatric HIV Observational Database (TApHOD) is a regio-
nal database including more than 4000 HIV-infected chil-
dren and adolescents in Thailand, Cambodia, Malaysia,
India, Indonesia and Vietnam. A report from the TApHOD
database in 2011, at a time when one-third of children in
the cohort were older than 12 years, showed that more
than two-thirds of adolescents had lost at least one parent
and the majority were cared for by grandparents or rela-
tives [52]. Countries with the largest number of adolescents
living with HIV in the region are India, Indonesia, Thailand,
Myanmar, and Vietnam.
One of the challenges faced by PHIV adolescents transi-
tioning to adult services in AP is that of not being fully
disclosed of their diagnosis. The World Health Organization
guideline recommends informing children of their HIV sta-
tus between the ages of 6–12 years. However, many
parents and care providers choose the easier option of
letting adolescents ‘discover by themselves’ about their
illness. A study among 260 children/adolescents in a pae-
diatric HIV centre in Thailand showed that the median age
of disclosure was 14.8 years [53]. PHIV adolescents usually
have their medical care arranged by caregivers, and receive
a one-stop service for HIV care. Therefore, they need pre-
paration to understand their own health, be aware of their
HIV status and be able to self-care and seek medical care in
the adult healthcare system.
Healthcare services and transition process
Examples of transition models are given in Box 1.
Caribbean, Central America and South America (CCASA)
In CCASA, many paediatric HIV clinics have established
dedicated clinical settings for the adolescent population
and most provide care for adolescents regardless of mode
of acquisition with many BHIV adolescents referred from
sexually transmitted disease and pregnancy clinics.
Programmatic data from Haiti demonstrate the positive
impact of youth-friendly adolescent HIV services on the
proportion of young people initiating ART [56]. A propor-
tion of youth living with HIV in CCASA are already parents
[57], most of whom are still being followed at adolescent
clinics, where they have, many times, built strong bonds.
Box 1. Examples of different transition models
Jamaica
Children are routinely transitioned into adult care within the
public sector at the age of 12 years, although at two paediatric
sites transitioning happens as late as 24 years. Within the
Jamaica Paediatric Perinatal and Adolescent HIV/AIDS
Programme (JaPPAAIDS) transition is supported through
involvement of a psychologist and intensive follow-up; there are
plans to rollout this model to other sites in Jamaica [54].
Ukraine
HIV care for children and adults is provided at regional HIV
centres; transfer to adult care involves a change of doctor
within the same centre and usually occurs at 18 years, with
some flexibility depending on the policy of the centre. Transfer
is normally preceded by a period of shared care between the
paediatrician and adult doctor [31].
Thailand
At Chiangrai Prachanukroh Hospital in Chiang Rai province, a
group transition programme started in 2008. Young people who
are ready to transfer are selected by paediatric providers and
case conferences held with adult providers, the hospital’s home
care team and clinical psychology consultants. The young
people attend a camp for 1–2 days to prepare them for
transition and then attend adult clinic as a group, accompanied
by a paediatric provider for the first few appointments [55].
Bailey H et al. Journal of the International AIDS Society 2017, 20(Suppl 3):21475
http://www.jiasociety.org/index.php/jias/article/view/21475 | http://dx.doi.org/10.7448/IAS.20.4.21475
52
Data from CCASA indicate that PHIV or BHIV adolescents
receiving care in adolescent clinics, as well as their health-
care professionals, may perceive the prospect of transition-
ing to adult clinics as a threatening event which entails a
rupture in relationships [58,59] or be intimidated by the
atmosphere of an adult clinic [54]. In an example of a
model aiming to support the transition process at an
Adolescent Clinic in São Paulo, Brazil, readiness of young
people to transition is evaluated (e.g. clinically and emo-
tionally stable, adequate social support, and knowledge
about HIV and ART) along with preparation in paediatric
services followed by more intensive follow-up in adult ser-
vices in the year following transition [60]; qualitative find-
ings from young people post-transition showed that some
reported insecurity in relationships with adult care provi-
ders and in expectations for the future [60]. Unfortunately,
in CCASA, most specialized health services are not well
connected with community-based and educational
resources that could help transform life perspectives and
empower youth for adult life. Strategies such as case man-
agement are not routinely available in services of the
region.
Eastern Europe (EE)
In Russia, Ukraine and some other countries of the for-
mer Soviet Union, HIV care for children and adults is
delivered through a network of regional HIV centres.
Linkages to other services (e.g. for TB treatment) are
often weak [61]. However, progress has been made to
decentralize ART provision in Ukraine in recent years
[62]. Typically, HIV-positive children in Ukraine are
cared for by a paediatrician until 18 years, when they
transition to adult services within the same centre [31].
In Russia, some centres follow a similar system while
others follow a family-based model whereby young peo-
ple continue to be seen by the same infectious diseases
doctor into adulthood (personal communication, Anna
Turkova 2016). This model is also followed by the
“Dr Victor Babes” Hospital for Infectious and Tropical
Diseases Bucharest, one of the HIV referral centres in
Romania (personal communication, Luminita Ene, 2016).
Where paediatric and adult HIV care are provided by
different specialists, the setting in which a young person
begins their care is determined by age at diagnosis;
issues around transition of care therefore apply to BHIV
young people diagnosed aged <18 years as well as PHIV.
However, delays in linkage to HIV care following diagno-
sis are particularly long for PWID (mean 3 years) and
young people [63] and the proportion of BHIV entering
paediatric HIV services is therefore likely to be quite
small. ART access for children has been prioritized in EE
and currently ART coverage is >90% in Ukraine and 75%
in Russia [10,23,27] vs. around 50% and 34% among
adults, respectively [23,64]. Access to some aspects of
HIV care such as ARV resistance testing is poor or uneven
[61] and young people and their families may face addi-
tional barriers including illegal charging of users fees for
non-HIV-specific services [65–68] and poor access to sex-
ual and mental health services [69,70].
Asia and Pacific (AP)
In AP, the process of transition depends on the clinical
setting; large hospitals such as university hospitals or regio-
nal hospitals have separate paediatric and adult HIV clinics,
therefore formal patient transfer between clinics is needed.
In general, the cutoff age for transfer from paediatric to
adult services is 15 years. In smaller service delivery centres
such as provincial hospitals, healthcare workers must pro-
vide HIV care to all groups of patients, including pregnant
women, children and adults, therefore, transition to adult
care is implemented only through an adjustment of the
mindset and the approach healthcare workers employ
with patients once they reach adolescence.
The majority of healthcare providers surveyed within the
TREAT Asia network in December 2012 felt the most appro-
priate age of transition to be between 18–20 years [71].
The main barriers for transition to adult care included
perceived lower quality of care in adult services, less ado-
lescent-friendly HIV care settings, and less expertise in
adolescent psychosocial needs. Solutions suggested by sur-
vey respondents for smooth transition included disclosure
of HIV status, preparation for transition 1–3 years in
advance, preparation of up-to-date medical summaries,
identifying adult HIV clinicians with an interest in the tran-
sitioning population and assignment of staff to oversee the
transition process. Other supportive measures included
engaging the multidisciplinary team at both paediatric and
adult levels, maintaining relationships with transitioned
adolescents, and encouraging the patient’s family to take
responsibility within the transition process. An interview
among 19 HIV-infected Thai youth regarding the transition
process, 9 of whom had already transitioned, found that
they were fearful of the sudden increase in responsibility
when navigating through adult HIV services with less psy-
chosocial and adherence support, and of disclosure of
details of their infection to other adults [71]. The group
brainstormed solutions to alleviate these fears, such as
education about medications, how to manage medical
appointments, and preparation on communication skills
and building relationships with adult healthcare service
providers.
Several initiatives in AP have aimed to empower ado-
lescents living with HIV and prepare them to become
independent young adults. A study conducted in
Vietnam asking healthcare workers about concerns of
adolescents living with HIV found an urgent need for
education about sexual health and disclosure [72].
UNESCO in collaboration with the Ho Chi Minh
Communist Youth Union and the Ministry of Education
and Training produced “As We Grow Up” and “Happy
living with ‘H’” booklets, which provide adolescents
with knowledge on healthy sexuality and lifestyles, HIV
knowledge, strategies for dealing with stigma and discri-
mination, as well as coping skills in an adolescent-friendly
format. Between 2014 and 2015, several national training
workshops for healthcare workers were held throughout
Vietnam to introduce the concept of transition and to
launch these booklets in an effort to increase support for
adolescents living with HIV. A 2015 intervention
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programme in Thailand designed for adolescents called
the “Happy Teen Program”, which focused on improving
health knowledge, coping skills, sexual risk reduction and
life goal setting, was piloted and implemented using
individual counselling sessions and group work [9].
Outcomes in paediatric and adolescent care
Caribbean, Central America and South America (CCASA)
Data from the Caribbean, Central and South America
Network for HIV Epidemiology (CCASAnet) cohort on 903
adolescents living with HIV in Argentina, Brazil, Chile, Haiti,
Honduras, Mexico and Peru [8], of whom 53.8% were
female, indicated that at last study visit 90% were on
combination ART (cART), median CD4 count was 598
cells/mm3 (IQR 377–860) and 70% were considered virolo-
gically suppressed (<400 copies/mL) with median WHO
height-for-age z-score of −1.59. Mortality between age 10
and 15 years was 4.4% (95%CI 3.1–6.1). A multicentre
Brazilian survey among 260 children and adolescents
receiving routine care at referral centres found 57% of
children and 49% of adolescents with viral suppression
(<50 copies/ml) [73]. This same study observed that at
entry to paediatric HIV care, 44.6% of children had already
progressed to either an AIDS defining illness or CD4 per-
centage <15%. In another study of 387 children aged
1–11 years from Brazil, Peru and Mexico, 57.6% had a
viral load <400 copies/ml [74]. There are no available data
on neuropsychological aspects or cognition among adoles-
cents living with HIV in CCASA; however, a Brazilian study
found a high frequency of school failure and drop-out (51%
and 28.6% respectively) among adolescents living with HIV
in the northeast region of the country [75]. Non-adherence
to treatment is frequent, sometimes indicating psycho-
social situations (e.g. lack of self-efficacy) which need atten-
tion [76], while family social isolation, stigma (and resulting
issues around disclosure [77]), anxiety and depression, and
substance misuse are examples of common challenges that
affect treatment outcomes of children and adolescents.
Some of these situations can be identified and addressed
during follow-up of adolescents and their caregivers
[73,78,79].
Eastern Europe (EE)
In EE, data on outcomes in paediatric care are available
within the European Pregnancy and Paediatric HIV Cohort
Collaboration (EPPICC) from the Ukraine Paediatric HIV
Cohort set up in 2011, and for Russian sites in St
Petersburg and Irkutsk which have participated in EPPICC
since 2012. Analyses within EPPICC have indicated that
children in these two countries have poorer response to
cART than children in Central /Western Europe, with a
significantly lower probability of reaching virological sup-
pression of <400 copies/ml by 12 months after cART
initiation (aHR 0.73, 95% CI 0.64–0.84, after adjusting
for other factors including age and calendar year at
cART initiation) [80]. This finding may be partly due to
targeted viral load testing of children with poor CD4
response or clinical signs of treatment failure, in settings
with limited viral load testing capacity; results from the
Ukraine cohort indicate good rates of virological suppres-
sion of 88% at last follow-up among both older
(≥14 years) and younger children on a stable ART regimen
for the preceding 6 months [10], similar to the 92% (95%
CI 91–94) virological suppression rate seen by 12 months
among 997 children in the UK/Ireland cohort [81]. EPPICC
analyses have also indicated that children in Ukraine and
Russia are slower to switch to second-line therapy than
those in Western Europe [82], possibly due in part to
poorer availability of second-line drugs. Studies in
Romania indicate low rates of school completion and
high prevalence of neurocognitive dysfunction among
HIV-positive adolescents [39,40], with greater risk of HIV
disease progression and/or death among those whose HIV
status was not disclosed [83] or in families with lower
socio-economic status [84].
Asia and Pacific (AP)
In AP, data from the TREAT Asia network indicate that in
paediatric services, more than 80% of treated adolescents
had a good virological outcome (<400 copies/ml) [52].
Aurpibul in 2015 reported on a cohort of 107 Thai children
enrolled in an ART programme since 2002; at 10 years
follow-up (median current age, 17.8 years), 8% had died,
8% had been referred to decentralized ART services, 84%
remained in follow-up, 77% had viral suppression and 71%
had CD4 counts of >500 cells [85]. Data on neurocognitive
function among older children in Thailand and Cambodia
showed that HIV-infected children had lower cognitive
function compare to HIV-negative children (mean full
scale IQ 75 versus 90) despite receiving cART, which may
in turn affect their ability to self-care and transition to adult
clinic [86].
Transition outcomes: current data and ongoing research
Published data on outcomes of young people transitioning
to adult HIV care in CCASA, EE and AP are very limited to
date. This is due to the comparatively young PHIV popula-
tion in some countries across these regions and the histor-
ical lack of paediatric studies and surveillance data with
sufficient duration of follow-up in some of the most
affected countries, which provide the basis for tracking
young people into adult care. The main findings from five
published studies on transition outcomes across these
regions are given in Table 1. The studies highlight some
common issues including poor rates of retention in care
and suboptimal virological suppression due to ongoing poor
adherence and/or exhaustion of treatment options.
Caribbean, Central America and South America (CCASA)
A study from Argentina highlighted substantial treatment
experience of adolescents at the point of transition to adult
care; among 11 young people with virological failure, median
treatment duration was 15 years (IQR 12–16) with median 3
ART regimens (IQR 3–9) [87]. In a study in Brazil, three-quarters
of the 41 young people had received mono or dual therapy
before beginning cART, with a median 4 previous ART regi-
mens by the time of transfer to adult care [88]. Problems with
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adherence and retention in paediatric care persisted following
transition to adult care (Table 1).
Within CCASAnet, planned studies of HIV-positive youth
include two projects soon to begin on pregnancy outcomes
in young PHIV and BHIV women, to include investigation of
retention in care after delivery (personal communication,
Catherine McGowan, 2017).
Eastern Europe (EE)
The only study from EE was among 19 BHIV and 1 PHIV
18 year old who transferred from paediatric to adult HIV
care in St Petersburg, Russia in 2013–2015; very high
rates of loss to follow-up (13/16 among those who
remained in the region) were reported [89]. However,
the barriers to retention in adult care experienced by
sexually infected youth may differ from those faced by
PHIV adolescents (who comprise the majority of those in
paediatric care). Data from the adult population in EE
highlight particular adherence challenges faced by young
women, with over half of those aged <25 years in a
Ukraine cohort reporting that they had missed a dose
in pregnancy compared with only 23% aged
25–27 years [91].
Data collection on outcomes of young people in adult HIV
services (including those transferring from paediatric care) is
ongoing in Ukraine, within a research project building on the
Ukraine Paediatric HIV Cohort and funded by the International
AIDS Society’s Collaborative Initiative for Paediatric HIV
Table 1. Transition outcomes of HIV-positive young people transferring to adult care in the Caribbean, Central America and
South America, Eastern Europe and Asia and Pacific
Region Country
Year
of
study Study population Main findings Ref
CCASA Argentina 2015 37 perinatally infected adolescents transitioning to
adult care centre “Cosme Argerich” Hospital,
Buenos Aires, Argentina in 2005–2011
● Of the 37 who transitioned in this time period,
62% (n = 23) had ongoing virological failure
● Among 11 of the 23 adolescents included in a
detailed study on virological failure, 10 had tri-
ple-class experience and five had triple-class
resistance
[87]
CCASA Brazil 2016 41 young people (39 perinatally infected)
transferring to adult HIV care at an HIV outpatient
clinic in Sao Paulo, median age 19 years at first
adult clinic visit.
● Median CD4 count at first adult clinic visit was
250 cells/mm3 (IQR 94–460) and 46% (n = 19)
had a viral load <400 copies/ml
● Around 70% had adherence failure in the final
two years of paediatric care (according to a
composite measure including missed ART and/or
clinic appointments) and a similar proportion in
the first two years of adult care.
[88]
EE Russia 2016 20 adolescents (18 years) who transferred to adult
care in St Petersburg in 2013–2015, 19
behaviourally and 1 perinatally infected
● By 2016, 3 remained in active follow-up; 4 had
been referred to other centres; 13 were lost to
follow-up
[89]
AP Thailand 2015 67 young people transitioning from paediatric to
adult care at Chiangrai Prachanukroh Hospital
between 2008–2014 at >18 years of age
● By March 2015, 73% (n = 49) remained in active
follow-up; 13% (n = 9) had been lost to follow-
up; 7% (n = 5) had been referred to other hos-
pitals; 6% (n = 4) had died.
● Two of four deaths took place within 8 months of
transitioning and two deaths after >2.5 years. All
four deaths were in patients with non-sup-
pressed viral load at time of transition to adult
care.
● Of the 49 remaining in active follow up in 2015,
76% had a viral load <40 copies/ml.
[55]
AP Malaysia 2016 21 adolescents who had transitioned to the
adolescent transition clinic at Institut Pediatrik,
Hospital Kuala Lumpur (a tertiary referral centre)
in 2010–2015
● Only one of the 21 patients had been lost to
follow-up by 2016
● Some patients required switching of their cART
due to treatment failure, however there were
few risky health behaviours and all patients were
doing well and in employment
[90]
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Education and Research (CIPHER) programme. This project
includes a computer-assisted self-interview of 13–24 year
olds at two sites to support incorporation of their needs into
transitional programs. More broadly within EPPICC, research
currently in development aims to characterize the population
at transition and the subsequent outcomes.
Asia and Pacific (AP)
A study from Thailand evaluated transition outcomes of 67
adolescents who prepared for transition through a two day
camp where they were introduced to the adult care team in
groups of 10–15, before transitioning to the adult HIV clinic
in the same hospital (Table 1 [55]). Five years post transi-
tion, the majority remained in follow-up care with good
virological outcomes. It was found that having adolescents
visit adult services with the paediatric team facilitated posi-
tive peer interactions that provided resilience against poor
drug compliance, alcohol use, difficult family relationships
as well as other life issues. In Malaysia, a structured, multi-
disciplinary transition programme at the Institut Pediatrik
Hospital Kuala Lumpur, a large tertiary centre, also demon-
strated good outcomes with only one patient of 21 lost to
follow-up in five years of follow-up [90].
The Study of Transitioning Asian Youth (STAY) is aiming
to describe transition outcomes of PHIV adolescents in
terms of retention in care, adherence to ART and virological
suppression rate after transfer to adult care with annual
visits and biannual online/mobile surveys [54]; Enrolment
of 100 HIV-infected adolescents in Thailand, Malaysia, and
Vietnam into this study started in 2016 (personal commu-
nication, Annette Sohn, 2017).
Future research priorities
Across CCASA, EE and AP, there are key evidence gaps
regarding development of evidence-based clinical practice
guidelines tailored to the country context to support tran-
sitioning youth. Increasing numbers of young people are
anticipated to transition to adult care in the coming years
against a backdrop of increasing numbers of adults on
treatment, as the WHO 2015 guidelines recommending
ART for all PLWH are incorporated into national guidelines,
with implications for burden on adult services. The period
of 18–25 years of age, presently understood in developed
countries as “emerging adulthood” [92], is likely to be
experienced differently among HIV-positive youth in
CCASA, EE and AP compared with high-income or high
prevalence settings, but HIV services and/or research for
children and young people are sometimes given low priority
within national policy agendas [93]; data are needed to
inform advocacy for this group.
As in other regions, robust monitoring and longitudinal
research studies on PHIV and BHIV adolescents are urgently
needed to expand the currently very sparse data on transi-
tion outcomes such as retention rates, virological suppres-
sion and patient quality of life, and to guide future
management strategies. The diverse models of healthcare
for HIV-positive young people and different initiatives to
support them that we describe highlight the need to estab-
lish common definitions and outcome measures, to
facilitate within and between country comparisons. Young
adulthood is a time of geographical mobility, and structural
barriers to HIV care imposed by insurance or programmatic
constraints may also be barriers to research. For example,
HIV care in Thailand is supported by the national health
security office for the general population, and the social
security office (SSO) for those in employment. As adoles-
cents begin to enter the workforce, their healthcare is
transferred to the SSO, which can only be received at
specific hospitals, often forcing them into transition without
a preparation phase. This may compromise their outcomes
and research efforts to follow them post-transition. In
Ukraine and Russia, follow-up of HIV-positive young people
from paediatric to adult care is possible within regional HIV
centres; however, conflict in the East of Ukraine had
resulted in displacement of >1.7 million people, including
228,000 children [94], and consideration needs to be given
to the research challenges of tracking this vulnerable popu-
lation within national HIV care systems. National data dis-
aggregated by adolescent and young adult age groups are
unevenly available across these regions but are crucial for
the planning of services.
Long duration of ART with exposure to sequential changes
in regimens and accumulation of resistance mutations is a
special challenge for professionals caring for PHIV young
people [57,87,95–97]. Work in CCASA has demonstrated the
importance of ensuring a comprehensive approach to ado-
lescent HIV care in which factors affecting treatment out-
comes can be identified and addressed before the
transitioning process begins [73,78,79]. Peer support may
improve outcomes [55,98]; however, young people across
CCASA, EE and AP who are part of stigmatized or criminalized
groups including MSM, sex workers, PWID or their sexual
partners may face particular challenges in accessing this.
Many adolescent clinics in CCASA are admitting MSM youth
who subsequently identify as transgender females. Some
paediatricians have personal and technical difficulties in fol-
lowing these patients and the transitioning process in these
cases may occur prematurely. This is a very sensitive and
challenging situation that deserves attention; transgender
youth may face personal crisis during the period where
transition is expected to occur and the non-observance of
their specific needs may have direct impact on (future) treat-
ment adherence and retention in care. Further work is
needed to understand how the linkage of healthcare services
to youth-centred community-based initiatives, particularly
professionalizing resources, may facilitate social support and
professional integration alongside the transitioning process
and support post-transitioning outcomes.
Conclusions
Limited data available from CCASA, EE and AP to date
indicate uneven outcomes in paediatric services and some
shared challenges during adolescence and transition,
including retention in care and maintenance of virological
suppression against a backdrop of adherence problems or
exhaustion of treatment options. The impact of other con-
text-specific challenges on young people in these regions
Bailey H et al. Journal of the International AIDS Society 2017, 20(Suppl 3):21475
http://www.jiasociety.org/index.php/jias/article/view/21475 | http://dx.doi.org/10.7448/IAS.20.4.21475
56
are poorly understood to date. A range of transitional care
models are currently being implemented and/or developed
in countries across the regions, and there is an urgent need
for setting-specific outcome data to inform development of
resilient and sustainable systems which can support young
PLWH during adolescence and young adulthood in years to
come.
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